Get UpdatesFebruary 13, 2026

Intermittent Fasting Shows Promise for Crohn's Disease in Breakthrough Trial

New research reveals powerful health interventions, from time-restricted eating cutting Crohn's symptoms by 40% to a kefir-fiber combo that outperforms omega-3s for inflammation.

8-Hour Eating Window Cuts Crohn's Disease Symptoms by 40%, Major Trial Finds

A groundbreaking randomized clinical trial from the University of Calgary has found that time-restricted eating dramatically reduces Crohn's disease activity and inflammation. The study, published in Gastroenterology, followed 35 adults with Crohn's disease and overweight or obesity over 12 weeks.

Participants who limited their eating to an 8-hour daily window experienced a 40% reduction in disease activity and a 50% decrease in abdominal discomfort, compared to those following regular eating patterns. Remarkably, these benefits occurred without any changes to what participants ate—only when they ate changed. Participants also lost an average of 5.5 pounds and showed improved inflammation markers.

This is the first randomized controlled trial to demonstrate that intermittent fasting can help manage inflammatory bowel disease. Lead researcher Dr. Maitreyi Raman emphasized that patients should consult healthcare providers before changing eating schedules, but the findings offer hope for a simple, accessible intervention alongside standard treatments.

Research shows time-restricted eating reduced Crohn's disease symptoms by 40% in clinical trial
Research shows time-restricted eating reduced Crohn's disease symptoms by 40% in clinical trial
sciencedaily.com·ucalgary.ca·crohnscolitisfoundation.org

Kefir and Fiber Combination Outperforms Omega-3 Supplements for Fighting Inflammation

A six-week study from the University of Nottingham has identified a powerful duo for reducing chronic inflammation. Published in the Journal of Translational Medicine, the research found that combining fermented kefir with a diverse prebiotic fiber blend produced superior anti-inflammatory effects compared to omega-3 supplements or fiber alone.

The study examined 104 healthy adults across three trials, with participants receiving either a synbiotic combination (170 ml kefir plus 10 grams prebiotic fiber daily), omega-3 capsules, inulin fiber, or no supplements. While all interventions reduced inflammation markers, the synbiotic combination showed the broadest and most significant decreases in inflammation-related proteins.

Lead researcher Dr. Amrita Vijay from Nottingham's School of Medicine explained that by feeding beneficial gut microbes and helping them produce compounds like butyrate, the combo appeared to improve overall immune balance and metabolic health. The findings suggest that pairing probiotics with prebiotics may be more effective than single-nutrient approaches for managing chronic inflammation.

Kefir combined with prebiotic fiber showed superior anti-inflammatory effects in new study
Kefir combined with prebiotic fiber showed superior anti-inflammatory effects in new study
sciencedaily.com·nottingham.ac.uk·translational-medicine.biomedcentral.com

WHO Review Highlights GLP-1 Weight Loss Success—But Warns of Rapid Weight Regain

Three major reviews commissioned by the World Health Organization reveal both promise and concerns about blockbuster GLP-1 drugs like Ozempic, Mounjaro, and Zepbound. The Cochrane reviews, published February 11, found that all three medications produce clinically meaningful weight loss, with tirzepatide leading at 16% average reduction, followed by semaglutide at 11%, and liraglutide at 4-5%.

However, researchers emphasized significant concerns about long-term use. Stopping the medications often leads to rapid weight regain, with studies showing an average rebound of 12 pounds after discontinuation. More troubling, people using GLP-1s tend to lose muscle mass first—between 15% to 60% of weight lost is lean muscle—but regain primarily fat when stopping, creating potentially harmful yo-yo dieting effects.

The reviews also noted that a substantial portion of studies received pharmaceutical company funding, raising conflict-of-interest concerns. High costs currently limit access to newer GLP-1s, while gastrointestinal side effects cause some patients to discontinue treatment. Researcher Eva Madrid noted that weight regain after stopping may affect the long-term sustainability of benefits.

New WHO-commissioned reviews examine benefits and risks of GLP-1 weight loss medications
New WHO-commissioned reviews examine benefits and risks of GLP-1 weight loss medications
sciencedaily.com·cochrane.org·cnn.com

What You Can Do

Explore Time-Restricted Eating

Learn about intermittent fasting approaches and consult healthcare providers about whether time-restricted eating could benefit your health goals.

crohnscolitisfoundation.org·healthline.com

Try Kefir and Prebiotic Foods

Incorporate fermented foods like kefir along with fiber-rich prebiotics into your diet to support gut health and reduce inflammation.

healthline.com